CLY

CLINDAMYCIN

Find entries where: CLY

is present as a standalone ligand in 6 entries

Find related ligands:

Chemical Component Summary
Name	CLINDAMYCIN
Identifiers	(1R,2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-oxan-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide
Formula	C₁₈ H₃₃ Cl N₂ O₅ S
Molecular Weight	424.983
Type	NON-POLYMER
Isomeric SMILES	CCC[C@@H]1C[C@H]([N@@](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl
InChI	InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1
InChIKey	KDLRVYVGXIQJDK-AWPVFWJPSA-N

Chemical Details
Formal Charge	0
Atom Count	60
Chiral Atom Count	9
Bond Count	61
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB01190
Name	Clindamycin
Groups	approved vet_approved
Description	Clindamycin is a semi-synthetic lincosamide antibiotic used in the treatment of a variety of serious infections due to susceptible microorganisms[L11599,L11596] as well as topically for acne vulgaris.[L11593] It has a relatively narrow spectrum of activity that includes anaerobic bacteria as well as gram-positive cocci and bacilli and gram-negative bacilli.[A190621] Interestingly, clindamycin appears to carry some activity against protozoans, and has been used off-label in the treatment of toxoplasmosis, malaria, and babesiosis.[A190657] Clindamycin is derived from, and has largely replaced, [lincomycin], a naturally occurring lincosamide and the eponymous member of this antibiotic class, due to its improved properties over the parent compound. The name lincomycin is derived from Lincoln, Nebraska, where it was first isolated from _Streptomyces lincolnensis_ found in a soil sample.[A190621]
Synonyms	7-CDL Clindamycine Clindamycin hydrochloride Clindamycin Clindamycinum 7(S)-Chloro-7-deoxylincomycin Clindamycin phosphate Clindamycin palmitate hydrochloride Clindamicina Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Brand Names	Clindamycin Injection USP Med-clindamycin Dalacin Vaginal Cream Teva-clindamycin Cabtreo Adapalene 0.3% / Benzoyl Peroxide 2.5% / Clindamycin 1% Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% Clindacin ETZ Ag-clindamycin Clindamycin Injection In 5% Dextrose Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025% Dalacin C Phosphate Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 4% Clindamycin hydrochloride Clindacin P Clindagel Riva-clindamycin Clindamycin Phoaphate Topical Solution, 1% Dalacin C Flavoured Granules Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate Topical Solution USP, 1% Clinda-T Neuac Kit Clindamycin HCL Cleocin Pediatric Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 4% Acanya Clindamycin Phosphate 1.2% and Tretinoin 0.025% Clinda-Derm Clindamycin IV Infusion CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) Cleocin Phosphate (0009-6582) (standalone) Clindamycin Palmitate Hydrochloride (pediatric) Duac Priva-clindamycin Dalacin C 150 mg Truemed Group LLC NuCaraRXPAK Clindoxyl Gel Veltin Clindamax Clindamycin Phosphate Clindacin Onexton Adapalene 0.1% / Benzoyl Peroxide 2.5% / Clindamycin 1% Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.1% Clindamycin 1% / Niacinamide 4% / Tretinoin 0.05% Benzoyl Peroxide 2.5%, Clindamycin Phosphate 1%, Niacinamide 2% / Tretinoin 0.05% Clindamycin and Benzoyl Peroxide Cleocin Hydrochloride Clindamycin Phosphate and Tretinoin Taro-clindamycin/benzoyl Peroxide Gel M-clindamycin Clindamycin Injection, USP Dalacin C 300 mg Clindacin PAC ClindaReach Clindamycin Palmitate Hydrochloride (Pediatric) Clindamycin Phosphate and Tretinion Clindamycin phosphate Evoclin Clindets Taro-benzoyl Peroxide / Clindamycin Kit Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05% Ava-clindamycin Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.05% Cleocin T Clindamycin Phoaphate Topical Solution USP, 1% CLIN-Single Use Kit Neuac Mylan-clindamycin Clindamycin Clindavix Xaciato Nra-clindamycin CLIN-LIDO-Single Use Kit Clindoxyl Adv Gel Clindamycin phosphate and benzoyl peroxide NuCaraClinPAK Clindamycin Injection Sdz Cleocin Phosphate Clindamycin Phosphate Injection USP Liq ClindaMax PMS-clindamycin Clindamycin Phosphate Topical Solution USP Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide Nu-clindamycin Benzoyl Peroxide 5% / Clindamycin1% / Niacinamide 2% / Tretinoin 0.025% Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05% Clindamycine-300 Clindesse Benzaclin Ratio-clindamycin Capsules - 300mg Auro-clindamycin Cleocin Jamp Clindamycin Clindamycin Phoaphate Topical USP, 1% Ratio-clindamycin Capsules-150mg Clindamycin in 5 Percent Dextrose Clindamycin 1% / Niacinamide 4% Biacna Topical Gel Clindamycin Palmitate Hydrochloride Clindamycine-150 Clindamycin - Benzoyl Peroxide Apo-clindamycin Clindasol Clindamycin 1% / Niacinamide 4% / Spironolactone 2% / Tretinoin 0.025% Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.05% Clindamycin 1% / Niacinamide 4% / Tretinoin 0.025% Clindap-T Ziana Dalacin T 1% Clindamycin 1% / Sodium Sulfacetamide Monohydrate 5% / Tretinoin 0.025% Taro-clindamycin Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.025% Clindamycin Hydrochloride Clindamycin 1% / Hydrocortisone 2.5% / Niacinamide 4% Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.025%
Indication	In oral and parenteral formulations, clindamycin is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria, as well as susceptible staphylococci, streptococci, and pneumococci.[L11599,L11602] Used topically, it is indicated for the treatment of acne vulgaris[L11593,L11611,L11605] and is available in combination with [benzoyl peroxide][L11584] or [tretinoin][L11590] for this purpose, or as a triple combination therapy with benzoyl peroxide and [adapalene].[L48666] Clindamycin is also indicated as a vaginal cream[L11596], suppository[L11608], or gel[L39416] for the treatment of bacterial vaginosis in non-pregnant females. Clindamycin is used for antimicrobial prophylaxis against _Viridans_ group streptococcal infections in susceptible patients undergoing oral, dental, or upper respiratory surgery, and may be used for prophylaxis against bacterial endocarditis in penicillin-allergic patients at high risk of these infections.[L11629]
Categories	Agents that produce neuromuscular block (indirect) Anti-Acne Preparations Anti-Acne Preparations for Topical Use Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antibiotics for Pneumocystis Pneumonia Antiinfectives for Systemic Use Antiinfectives for Treatment of Acne Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Decreased Sebaceous Gland Activity Dermatologicals Enzyme Inhibitors Genito Urinary System and Sex Hormones Glycosides Gynecological Antiinfectives and Antiseptics Lincomycins Lincosamide Antibacterial Lincosamides Macrolides Macrolides, Lincosamides and Streptogramins Neuromuscular Blockade Neurotoxic agents P-glycoprotein substrates Protein Synthesis Inhibitors Pyrrolidines
ATC-Code	D10AF01 J01FF01 D10AF51 G01AA10
CAS number	18323-44-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
50S ribosomal protein L1	MAKKGKKYQEAASKVDRTQHYSVEEAIKLAKETSIANFDASVEVAFRLGI...	unknown	inhibitor
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inhibitor
Alpha-1-acid glycoprotein 1	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAF...	unknown	substrate
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682